Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis U Požgan, D Caglič, B Rozman, H Nagase, V Turk, B Turk Biological chemistry 391 (5), 571-579, 2010 | 146 | 2010 |
Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation D Cavallo-Medved, D Rudy, G Blum, M Bogyo, D Caglic, BF Sloane Experimental cell research 315 (7), 1234-1246, 2009 | 135 | 2009 |
Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions D Caglic, JR Pungercar, G Pejler, V Turk, B Turk Journal of biological chemistry 282 (45), 33076-33085, 2007 | 118 | 2007 |
Autocatalytic processing of procathepsin B is triggered by proenzyme activity JR Pungerčar, D Caglič, M Sajid, M Dolinar, O Vasiljeva, U Požgan, ... The FEBS journal 276 (3), 660-668, 2009 | 114 | 2009 |
Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain D Caglič, MC Krutein, KM Bompiani, DJ Barlow, G Benoni, JC Pelletier, ... Journal of medicinal chemistry 57 (3), 669-676, 2014 | 55 | 2014 |
Functional in vivo imaging of cysteine cathepsin activity in murine model of inflammation D Caglič, A Globisch, M Kindermann, NH Lim, V Jeske, HP Juretschke, ... Bioorganic & medicinal chemistry 19 (3), 1055-1061, 2011 | 50 | 2011 |
The proinflammatory cytokines interleukin-1α and tumor necrosis factor α promote the expression and secretion of proteolytically active cathepsin S from human chondrocytes D Caglič, U Repnik, C Jedeszko, G Kosec, C Miniejew, M Kindermann, ... Biological chemistry 394 (2), 307-316, 2013 | 36 | 2013 |
Selective and sensitive monitoring of caspase-1 activity by a novel bioluminescent activity-based probe M Kindermann, H Roschitzki-Voser, D Caglič, U Repnik, C Miniejew, ... Chemistry & biology 17 (9), 999-1007, 2010 | 36 | 2010 |
Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: Extending towards the β-exosite GR Smith, D Caglič, P Čapek, Y Zhang, S Godbole, AB Reitz, ... Bioorganic & medicinal chemistry letters, 2012 | 16 | 2012 |
Murine and human cathepsin B exhibit similar properties: possible implications for drug discovery D Caglič, G Kosec, L Bojič, T Reinheckel, V Turk, B Turk Biological chemistry 390 (2), 175-179, 2009 | 12 | 2009 |
Silver nanoparticles on titanate nanobelts via the self-assembly of weak polyelectrolytes: synthesis and photocatalytic properties I Bračko, B Jančar, M Logar, D Caglič, D Suvorov Nanotechnology 22 (8), 085705, 2011 | 9 | 2011 |
Biochemical characterization and substrate specificity of autophagin-2 from the parasite Trypanosoma cruzi J Rajković, M Poreba, D Caglič, R Vidmar, A Wilk, A Borowik, G Salvesen, ... Journal of Biological Chemistry 290 (47), 28231-28244, 2015 | 8 | 2015 |
A high-throughput-compatible FRET-based platform for identification and characterization of botulinum neurotoxin light chain modulators D Caglič, KM Bompiani, MC Krutein, P Čapek, TJ Dickerson JoVE (Journal of Visualized Experiments), e50908, 2013 | 7 | 2013 |
High-Throughput Screening Uncovers Novel Botulinum Neurotoxin Inhibitor Chemotypes KM Bompiani, D Caglic, MC Krutein, G Benoni, M Hrones, LL Lairson, ... ACS Combinatorial Science 18 (8), 461-474, 2016 | 5 | 2016 |
Biochemical characterization of autophagin-2 from the parasite Trypanosoma cruzi J Rajkovic, G Kosec, M Poreba, M Drag, D Caglic, B Turk FEBS JOURNAL 279, 414-414, 2012 | | 2012 |
Small-molecule anticonvulsant agents with potent in vitro neuroprotection: Enhancing the pharmacokinetic properties of botulinum neurotoxin serotype A protease inhibitors … DE Brenneman, G Smith, Y Zhang, Y Du, SK Kondaveeti, MJ Zdilla, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 244, 2012 | | 2012 |
A coincidence detector triggers botulinum neurotoxin translocation D Caglič, TJ Dickerson Future Microbiology 7 (2), 185-188, 2012 | | 2012 |